Clovis Oncology
CLVS
#10297
Rank
โ‚ฌ10.1 M
Marketcap
0,06974ย โ‚ฌ
Share price
0.00%
Change (1 day)
-95.53%
Change (1 year)

Clovis Oncology (CLVS) Fails to deliver data

Key failure to deliver metrics for Clovis Oncology:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Clovis Oncology (CLVS) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Clovis Oncology (CLVS) - since 2013

Volume in USD (price x number of shares), data since 2013

Clovis Oncology (CLVS) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2022โ‚ฌ0.10 B55.95%
2021โ‚ฌ64.22 M-74.65%
2020โ‚ฌ0.25 B-49.12%
2019โ‚ฌ0.49 B1053.83%
2018โ‚ฌ43.14 M68.49%
2017โ‚ฌ25.6 M-50.75%
2016โ‚ฌ51.99 M5.81%
2015โ‚ฌ49.14 M-8.09%
2014โ‚ฌ53.46 M1150.43%
2013โ‚ฌ4.27 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
BioMarin Pharmaceutical
BMRN
โ‚ฌ2.8 Mโ‚ฌ17.38 M๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ21.14 Mโ‚ฌ0.11 B๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
โ‚ฌ24.63 Mโ‚ฌ0.10 B๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ54.31 Mโ‚ฌ94.31 M๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚ฌ21.44 Mโ‚ฌ0.10 B๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ0.21 Bโ‚ฌ0.37 B๐Ÿ‡บ๐Ÿ‡ธ USA